Found: 20
Select item for more details and to access through your institution.
PDE4B inhibition by nerandomilast: Effects on lung fibrosis and transcriptome in fibrotic rats and on biomarkers in human lung epithelial cells.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 23, p. 4766, doi. 10.1111/bph.17303
- By:
- Publication type:
- Article
Fibroblast–matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast‐conditioned matrix on normal fibroblast phenotype.
- Published in:
- Respirology, 2018, v. 23, n. 8, p. 756, doi. 10.1111/resp.13287
- By:
- Publication type:
- Article
BI 1015550 is a PDE4B Inhibitor and a Clinical Drug Candidate for the Oral Treatment of Idiopathic Pulmonary Fibrosis.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.838449
- By:
- Publication type:
- Article
Induced Syk deletion leads to suppressed allergic responses but has no effect on neutrophil or monocyte migration in vivo.
- Published in:
- European Journal of Immunology, 2011, v. 41, n. 11, p. 3208, doi. 10.1002/eji.201141502
- By:
- Publication type:
- Article
The Absence of Mrp4 Has No Effect on the Recruitment of Neutrophils and Eosinophils into the Lung after LPS, Cigarette Smoke or Allergen Challenge.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0061193
- By:
- Publication type:
- Article
Effects of the Phosphodiesterase Type 4 Inhibitor Roflumilast on Early and Late Allergic Response and Airway Hyperresponsiveness in Aspergillus-fumigatus-Sensitized Mice.
- Published in:
- Pharmacology, 2009, v. 83, n. 3, p. 188, doi. 10.1159/000196814
- By:
- Publication type:
- Article
Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension.
- Published in:
- Cardiovascular Research, 2019, v. 115, n. 2, p. 432, doi. 10.1093/cvr/cvy186
- By:
- Publication type:
- Article
Roflumilast Fully Prevents Emphysema in Mice Chronically Exposed to Cigarette Smoke.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2005, v. 172, n. 7, p. 849, doi. 10.1164/rccm.200411-1549OC
- By:
- Publication type:
- Article
Nintedanib modulates type III collagen turnover in viable precision-cut lung slices from bleomycin-treated rats and patients with pulmonary fibrosis.
- Published in:
- Respiratory Research, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s12931-022-02116-4
- By:
- Publication type:
- Article
Olodaterol shows anti-fibrotic efficacy in in vitro and in vivo models of pulmonary fibrosis.
- Published in:
- British Journal of Pharmacology, 2017, v. 174, n. 21, p. 3848, doi. 10.1111/bph.13982
- By:
- Publication type:
- Article
Olodaterol shows anti-fibrotic efficacy in in vitro and in vivo models of pulmonary fibrosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Nintedanib decreases muscle fibrosis and improves muscle function in a murine model of dystrophinopathy.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 7, p. 1, doi. 10.1038/s41419-018-0792-6
- By:
- Publication type:
- Article
The Effect of Nintedanib on T-Cell Activation, Subsets and Functions.
- Published in:
- Drug Design, Development & Therapy, 2021, v. 15, p. 997, doi. 10.2147/DDDT.S288369
- By:
- Publication type:
- Article
Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib.
- Published in:
- Drug Design, Development & Therapy, 2015, v. 9, p. 6407, doi. 10.2147/DDDT.S76648
- By:
- Publication type:
- Article
Fibrosing interstitial lung diseases: knowns and unknowns.
- Published in:
- European Respiratory Review, 2019, v. 28, n. 151, p. 1, doi. 10.1183/16000617.0100-2018
- By:
- Publication type:
- Article
Quantification of Pulmonary Fibrosis in a Bleomycin Mouse Model Using Automated Histological Image Analysis.
- Published in:
- PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0170561
- By:
- Publication type:
- Article
Nintedanib Reduces Muscle Fibrosis and Improves Muscle Function of the Alpha-Sarcoglycan-Deficient Mice.
- Published in:
- Biomedicines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/biomedicines10102629
- By:
- Publication type:
- Article
The long-acting β<sub>2</sub>-adrenoceptor agonist olodaterol attenuates pulmonary inflammation.
- Published in:
- British Journal of Pharmacology, 2015, v. 172, n. 14, p. 3537, doi. 10.1111/bph.13143
- By:
- Publication type:
- Article
Objective measurement of cough in pulmonary fibrosis: a cohort study - ImpaCT.
- Published in:
- ERJ Open Research, 2024, v. 10, n. 5, p. 1, doi. 10.1183/23120541.00310-2024
- By:
- Publication type:
- Article
Effects of Nintedanib in an Animal Model of Liver Fibrosis.
- Published in:
- BioMed Research International, 2020, p. 1, doi. 10.1155/2020/3867198
- By:
- Publication type:
- Article